Cargando…
Immunosuppressive therapy for progressive idiopathic membranous nephropathy: a cost-effectiveness analysis in China
BACKGROUND: This study aims to evaluate the cost-effectiveness of immunosuppressive therapy for patients with progressive idiopathic membranous nephropathy (IMN) from the Chinese healthcare system perspective. METHODS: To estimate the cost-effectiveness of four regimens namely cyclophosphamide, cycl...
Autores principales: | Xu, Wanyi, Zhang, Zhiqi, Li, Dandan, Dai, Wendi, Pan, Chen, Guo, Mingxing, Zhao, Ying, Cui, Xiangli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091593/ https://www.ncbi.nlm.nih.gov/pubmed/37046255 http://dx.doi.org/10.1186/s12913-023-09365-z |
Ejemplares similares
-
Pharmacokinetics and Dosing Regimens of Direct Oral Anticoagulants in
Morbidly Obese Patients: An Updated Literature Review
por: Zhao, Ying, et al.
Publicado: (2023) -
Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
por: Bao, Neng, et al.
Publicado: (2023) -
Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis
por: Bose, Bhadran, et al.
Publicado: (2022) -
Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database
por: Guo, Mingxing, et al.
Publicado: (2022) -
Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis
por: Ren, Song, et al.
Publicado: (2017)